| Product Code: ETC13276311 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Gastrointestinal Stromal Tumor Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 1.9 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The Global Gastrointestinal Stromal Tumor (GIST) Market is experiencing steady growth due to advancements in diagnostic techniques, increased awareness, and rising prevalence of GIST cases worldwide. The market is primarily driven by the development of targeted therapies such as tyrosine kinase inhibitors, which have significantly improved patient outcomes. Additionally, the growing geriatric population and changing lifestyle factors contribute to the increasing incidence of GIST, further fueling market growth. Key players in the market are focusing on research and development activities to introduce innovative treatment options and expand their product portfolios. However, challenges such as high treatment costs and limited accessibility to advanced healthcare facilities in developing regions may hinder market expansion. Overall, the Global GIST Market is poised for continued growth in the coming years, driven by technological advancements and increasing investments in healthcare infrastructure.
The Global Gastrointestinal Stromal Tumor (GIST) market is witnessing significant growth driven by advancements in targeted therapies, early diagnosis techniques, and increasing awareness among healthcare professionals and patients. Key trends include the development of personalized treatment approaches based on genetic profiling, the emergence of innovative combination therapies, and the focus on precision medicine. Opportunities in the market lie in the expansion of treatment options for refractory GIST cases, the growing adoption of immunotherapy in GIST treatment, and the potential for collaboration between pharmaceutical companies and research institutions to further enhance therapeutic outcomes. Additionally, the rising prevalence of GIST globally and the increasing investments in research and development are expected to drive market growth in the coming years.
The Global Gastrointestinal Stromal Tumor (GIST) market faces several challenges, including limited awareness among healthcare providers and patients leading to underdiagnosis, high treatment costs, and the emergence of generic competition for key therapies. Additionally, the rarity of GISTs compared to other cancers makes it difficult for pharmaceutical companies to justify investing in research and development for new treatments. Furthermore, the complexity of GISTs, with varying mutations and resistance mechanisms, poses a challenge in developing targeted therapies that are effective across all patient populations. Regulatory hurdles, such as stringent approval processes for novel treatments, also contribute to the challenges faced by stakeholders in the Global GIST market. Addressing these challenges will require collaboration among healthcare providers, pharmaceutical companies, regulators, and patient advocacy groups to improve outcomes for GIST patients.
The global gastrointestinal stromal tumor (GIST) market is primarily driven by factors such as increasing prevalence of GIST among the population, advancements in diagnostic techniques for early detection, and the development of targeted therapies for more effective treatment. Additionally, growing awareness about GIST, improving healthcare infrastructure in emerging economies, and rising investments in research and development activities are also contributing to market growth. Moreover, collaborations between pharmaceutical companies and research institutions to develop innovative treatment options and personalized medicine approaches are further fueling the market expansion. Overall, the market is expected to witness significant growth in the coming years as efforts continue to improve diagnosis, treatment outcomes, and patient care.
Government policies related to the Global Gastrointestinal Stromal Tumor (GIST) Market vary across countries but generally focus on ensuring access to affordable treatment options, promoting research and development for innovative therapies, and improving healthcare infrastructure for timely diagnosis and management of GIST. Policies may include funding for clinical trials, expedited regulatory pathways for new drugs, and guidelines for standard of care practices. Additionally, some governments offer reimbursement programs and patient assistance initiatives to support individuals with GIST in accessing necessary treatments. Overall, government policies in the GIST market aim to address the unmet medical needs of patients, encourage collaboration between stakeholders, and advance the overall quality of care for individuals affected by this rare form of cancer.
The Global Gastrointestinal Stromal Tumor (GIST) market is expected to experience steady growth in the coming years, driven by advancements in targeted therapies, increasing prevalence of GISTs, and rising awareness among healthcare providers and patients. The market is likely to witness the introduction of innovative treatment options, including personalized medicine approaches and combination therapies, leading to improved patient outcomes and quality of life. Additionally, ongoing research and development efforts focused on identifying novel biomarkers and therapeutic targets are anticipated to further propel market growth. However, challenges such as high treatment costs, regulatory hurdles, and limited accessibility to advanced treatments in developing regions may hinder market expansion to some extent. Overall, the Global GIST market is poised for continuous evolution and innovation in the foreseeable future.
In the global gastrointestinal stromal tumor (GIST) market, Asia is expected to witness significant growth due to the increasing prevalence of GIST cases in countries like China and Japan. North America is anticipated to dominate the market, driven by advanced healthcare infrastructure and high adoption of targeted therapies. In Europe, the market is projected to grow steadily, supported by favorable reimbursement policies and rising awareness about GIST among healthcare professionals. The Middle East and Africa region is likely to experience moderate growth due to improving healthcare facilities and increasing investments in oncology research. Latin America is also expected to show steady growth, driven by rising healthcare expenditure and improving access to innovative GIST treatments.
Global Gastrointestinal Stromal Tumor Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Gastrointestinal Stromal Tumor Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 & 2031F |
3.3 Global Gastrointestinal Stromal Tumor Market - Industry Life Cycle |
3.4 Global Gastrointestinal Stromal Tumor Market - Porter's Five Forces |
3.5 Global Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Global Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Global Gastrointestinal Stromal Tumor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Gastrointestinal Stromal Tumor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Gastrointestinal Stromal Tumor Market Trends |
6 Global Gastrointestinal Stromal Tumor Market, 2021 - 2031 |
6.1 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.1.3 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Targeted Therapy, 2021 - 2031 |
6.1.4 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.4 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.3.5 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.4.4 Global Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Gastrointestinal Stromal Tumor Market, Overview & Analysis |
7.1 North America Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 - 2031 |
7.2 North America Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6 North America Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Gastrointestinal Stromal Tumor Market, Overview & Analysis |
8.1 Latin America (LATAM) Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.4 Latin America (LATAM) Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.6 Latin America (LATAM) Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Gastrointestinal Stromal Tumor Market, Overview & Analysis |
9.1 Asia Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.4 Asia Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.6 Asia Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Gastrointestinal Stromal Tumor Market, Overview & Analysis |
10.1 Africa Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.4 Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.6 Africa Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Gastrointestinal Stromal Tumor Market, Overview & Analysis |
11.1 Europe Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.4 Europe Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.6 Europe Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Gastrointestinal Stromal Tumor Market, Overview & Analysis |
12.1 Middle East Gastrointestinal Stromal Tumor Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Gastrointestinal Stromal Tumor Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.4 Middle East Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Gastrointestinal Stromal Tumor Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.6 Middle East Gastrointestinal Stromal Tumor Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Gastrointestinal Stromal Tumor Market Key Performance Indicators |
14 Global Gastrointestinal Stromal Tumor Market - Export/Import By Countries Assessment |
15 Global Gastrointestinal Stromal Tumor Market - Opportunity Assessment |
15.1 Global Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.3 Global Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Gastrointestinal Stromal Tumor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.5 Global Gastrointestinal Stromal Tumor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Gastrointestinal Stromal Tumor Market - Competitive Landscape |
16.1 Global Gastrointestinal Stromal Tumor Market Revenue Share, By Companies, 2024 |
16.2 Global Gastrointestinal Stromal Tumor Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |